The CEHCR program […] shifted my perspective from focusing solely on individual patients to thinking about populations and systems.
When Dr. Shaurya Taran decided to pursue his PhD in Clinical Epidemiology and Health Care Research (CEHCR), he was motivated by a desire to better understand how health systems shape patient outcomes.
As a trained physician in neurocritical care, he brought extensive bedside experience. However, over time, he realized that some of the most challenging questions he was asking could not be answered through clinical experience alone.
“The CEHCR program provided exactly that foundation,” says Dr. Taran. “It shifted my perspective from focusing solely on individual patients to thinking about populations and systems.”
Once his studies were underway, he began to understand not only the outcomes of medical interventions, but also why they worked or did not, and for whom.
His supervisor, Dr. Neill Adhikari, recalls that Dr. Taran’s commitment and motivation were apparent from the outset.
“He came to IHPME with considerable enthusiasm and talent for research.”
According to Dr. Adhikari, Dr. Taran leveraged the program’s mentorship and training to produce high-impact work that continues to shape his post-PhD research agenda.
Now, as a graduate of the program, Dr. Taran approaches his clinical practice differently. Rather than focusing solely on treatments that target the biological aspects of illness, he looks beyond individual patients to understand how broader systems influence outcomes.
His current research reflects this shift, focusing on how decisions around the withdrawal of life-sustaining treatment shape outcomes for patients with severe brain injuries. Dr. Taran notes that while biological factors play a role in these decisions, they are also influenced by patients’ values, clinicians’ patterns of practice, and broader societal and cultural factors.
This systems-oriented perspective has also reshaped how he views clinical trials. Prior to his time at IHPME, he saw trials largely as isolated biological experiments. Now, he understands them as complex systems that interact with wider social and cultural influences.
His recent publication in Critical Care highlights that outcomes in severe brain injury are shaped not only by biology, but also by critical care decisions, raising important questions about bias in clinical trials and the evidence used to inform policy and practice.
“That systems-oriented approach is something I developed directly through my training at IHPME,” he says.
Today, Dr. Taran is driven by an overarching goal to improve long-term outcomes for patients with severe brain injuries who have survived critical illness.
He hopes his research will help generate stronger evidence to inform clinical guidelines, while also identifying and addressing biases in neurocritical care studies to produce more reliable evidence for health policy.
While clinical training begins at the bedside, Dr. Taran emphasizes the importance of stepping back to ask broader, system-level questions.
“Some of the most impactful research arises when frontline experience is combined with rigorous epidemiologic methods.”
This perspective continues to guide his work and, he believes, is key to achieving more meaningful and lasting improvements in healthcare.








